Diabetes Mellitus in the Pediatric Patient

Similar documents
associated with serious complications, but reduce occurrences with preventive measures

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Diabetes Mellitus. Mohamed Ahmed Fouad Lecturer of Pediatrics Jazan Faculty of Medicine

Type 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Type 2 Diabetes in Adolescents

Insulin Prior Authorization with optional Quantity Limit Program Summary

第十五章. Diabetes Mellitus

Helpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center

Pediatrics Grand Rounds 16 April University of Texas Health Science Center at San Antonio, Texas DISCLOSURES CYSTIC FIBROSIS-RELATED DIABETES

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

Distinguishing T1D vs. T2D in Childhood: a case report for discussion

Type I diabetes mellitus. Dr Laurence Lacroix

OVERVIEW OF PEDIATRIC DIABETES Alan B. Cortez, M.D. Pediatric Endocrinology Chief, Department of Pediatrics Kaiser-Permanente, Orange County

Pediatric Diabetes Update Fran R. Cogen, MD, CDE Professor of Pediatrics Director, Diabetes Services

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Clinical Practice Guidelines for Diabetes Management

The York Diabetes Care Model

Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1

Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives

For more information about how to cite these materials visit

Diabetes Related Disclosures

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011

Providing Stability to an Unstable Disease

Part XI Type 1 Diabetes

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

Comprehensive Diabetes Treatment

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE

AACN PCCN Review. Endocrine

Cystic Fibrosis Related Diabetes Mellitus (CFRD): A common rare disease

Nph insulin conversion to lantus

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Estimation of Blood Glucose level. Friday, March 7, 14

WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa

V. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof.

1. PATHOPHYSIOLOGY OF DIABETES MELLITUS

5/12/2011. Recognize the major types of diabetes: Type 2, Type 1A, Type 1B, MODY, LADA, Pancreatic diabetes, drug-induced DM

DIABETES MELLITUS. IAP UG Teaching slides

Medications for Diabetes

Type 1 Diabetes Update Robin Goland, MD

Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014

Lessons from conducting research in an American Indian community: The Pima Indians of Arizona

A PAPER DELIVERED ON THE CAUSES OF DIABETES

DOWNLOAD OR READ : TYPE 1 DIABETES IN CHILDREN HOW TO BECOME AN EXPERT ON YOUR OWN DIABETES PDF EBOOK EPUB MOBI

MANAGEMENT OF TYPE 1 DIABETES MELLITUS

Hormonal Regulations Of Glucose Metabolism & DM

Insulin Initiation and Intensification. Disclosure. Objectives

Medical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition

Diabetes Overview. Basics of Diabetes

Diabetes Mellitus, Type 1 (or Insulin-Dependent Diabetes Mellitus)

Diabetes Mellitus (DM) - Dr Hiren Patt

Type I Type II Insulin Resistance

Diabetes mellitus is a complex of syndromes characterized metabolically by hyperglycemia and altered glucose metabolism, and associated

Pathogenesis of Diabetes Mellitus


Lantus levemir conversion

Wayne Gravois, MD August 6, 2017

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville

Disclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2

Standards of Medical Care in Diabetes 2016

Lantus to levemir conversion

Objectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment

Diabetes School October 2016

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Early Indications of Type 1 Diabetes

Initiating Injectable Therapy in Type 2 Diabetes

Addressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:

Diabetes Mellitus II CPG

Diabetes Mellitus. Diabetes Mellitus. Insulin. Glucose. Classifications of DM. Other glucose regulating Hormones

Insulin 10/11/17. Disclosures. Objectives. Speaker and Consultant for Jansen and Healthscripts Speaker and Consultant for Boehringer Ingelheim (BI)

Drug Effectiveness Review Project Summary Report Long acting Insulins

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference

Screening for diabetes

Diabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE

PROBLEMS WITH REGULATION AND METABOLISM. Objectives A & P 8/11/2011

CE on SUNDAY Newark, NJ October 18, 2009

Diabetes Mellitus Type 2 Evidence-Based Drivers

Diabetes in Pregnancy

Chapter 37: Exercise Prescription in Patients with Diabetes

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Monthly WellPATH Spotlight November 2016: Diabetes

Health Status of Diabetic Patients in the Eastern Region of Libya

By: Dr. Doaa Khater Yassin, MM and M.D Paed Sr. specialist of Pediatrics SQUH

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Definition of diabetes mellitus

Degludec lantus conversion

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

Vishwanath Pattan Endocrinology Wyoming Medical Center

CARBOHYDRATE METABOLISM Disorders

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS

NAFLD AND TYPE 2 DIABETES

Disclosures. The Endocrine System. Objectives. Diabetes. The Endocrine System 4/5/17. Common Medications in Pediatric Endocrinology

Diabetes in the Young Athlete

Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products

Diabetes Mellitus Definition

Uncomplicated Diabetes Mellitus in Dogs Basics

INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.

Blood Sugar and Insulin

Transcription:

Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas

Disclosures None

Definitions to Know So you don t get stuck

Criteria for the Diagnosis of Diabetes Mellitus Symptoms of diabetes ( polyuria/polydipsia/weight loss) plus causal plasma glucose > 200 mg/dl or Fasting plasma glucose (FPG) > 126 mg/dl or 2 Hour PG > 200 mg/dl during an OGTT*

Impaired fasting glucose is defined by a plasma glucose: a. > 90 mg / dl b. 100 125 mg / dl c. 110 125 mg / dl d. > 125 mg / dl

Impaired fasting glucose is defined by a plasma glucose: a. > 90 mg / dl b. 100 125 mg / dl c. 110 125 mg / dl d. > 125 mg / dl

Diagnosis Impaired fasting glucose (IFG ) Fasting glucose 100 125 mg/dl Impaired glucose tolerance (IGT) 2 hr post prandial glucose 140 199 mg/dl

Simple Definition Diabetes = High BS 300 In a simple sense, diabetes is caused by either an absolute loss of insulin production (immune mediated beta cell destruction) - or - A relative insufficiency of insulin due to increased insulin needs beyond the ability of the pancreas to keep up.

Insulin Insufficiency & Diabetes Maximum insulin production capacity Insulin need less than insulin capacity Onset of symptoms 0 Type I Diabetes

Insulin Resistance & Diabetes Maximum insulin production capacity Insulin need less than insulin capacity Increasing insulin resistance Type II Diabetes Insulin need greater than insulin capacity

Insulin Resistance & Diabetes Maximum insulin production capacity Type II Diabetes The rise in insulin resistance and subsequent hyperglycemia often leads to a decline in beta cell function further worsening the insulin insufficiency

Diabetes Mellitus Basic Pathophysiology Type I - IDDM Insulin deficient Type II - NIDDM Insulin resistant +/- Insulin deficiency

Diabetes Mellitus Type 1 aka T1DM or IDDM

Epidemiology of IDDM Prevalence 1.2-1.9/1000 population IDDM affects males and females equally

Diagnosis of Type 1 DM Approximately 90% of white children will have autoantibodies at diagnosis. As many as 50% of children from other ethnic groups with new onset diabetes have type 2 diabetes.

Classification Type 1 1A Immune mediated 1B Nonimmune mediated Type 2 MODY Congenital Specific Genetic Syndromes

Comparison of the Common Forms of Youth Onset Diabetes Characteristic Type 1 Diabetes Congenital Diabetes MODY (monogenetic) Type 2 Diabetes Age at onset Peaks at 5 and 15 years old Predominant ethnic groups affected Birth <25 years old Teenage to young adult Caucasian None Caucasian Hispanic, African- American, Native American Islet autoimmunity Present Absent Absent Absent Insulin-dependent Yes Variable No No Percentage of probands with an affected firstdegree relative Mode of inheritance Pathogenesis <15% 100% Variable but common Sporadic Autoimmune betacell destruction: insulinopenia Autosomal dominant Sulfonylurea signaling Autosomal dominant Insulinopenia Strongly familial Insulin resistance plus relative insulinopenia

... Chromosome 6 C2B1TNF GLO DPDQDR B C T1DM related genes DR 3 DR 4 Account for 45% of genetic susceptibility for the disease Located within the HLA Class II region on chromosome 6p21

Genetics Relationship to proband Risk for IDDM (%) Mother 2 Father 6 Sibling 5 No HLA identity 1 HLA haploidentical 5 HLA identical 15 Monozygotic twin 33 HLA Genotypes Diabetes Mellitus Risk Potential DR 2 Protective DRB1*03/03;DQB1*0201/0201 1-2 DRB1*04/04;DQB1*0302/0302 1-5 DRB1*03/04;DQb1*0201/0302 6-10 DRB1*X/X;DQB1*0602/X 0.02-0.1 DR 3 / DR 4 Increased Risk

The most common cause of T1DM is: a. Autoimmunity b. Immunizations c. Early cow s milk feeding d. Cystic fibrosis e. Virus destruction of beta cells

The most common cause of T1DM is: a. Autoimmunity b. Immunizations c. Early cow s milk feeding d. Cystic fibrosis e. Virus destruction of beta cells

Type 1 Diabetes Mellitus Etiology Toxins Autoimmunity Pancreatic Destruction (Cystic Fibrosis)

Immune Mimicry T cell T cell T cell T cell T cell Virus Pancreas Coxsackie, mumps, etc. T cell T cell T cell Macrophage Autoimmune Diabetes Mellitus

Associated autoimmune diseases Thyroid disease 10-20% Celiac disease 5% Addison s disease 1 in 200-500 Others: Vitiligo, SLE, Crohn s disease, vitamin B12 deficiency, hepatitis, premature ovarian failure.

Clinical Presentation How do children with new onset diabetes mellitus generally present? Answer : With the 3 P s... Weight Loss

Management Goals Physical and emotional well being Normal growth and development Avoid acute and chronic complications Normal HgbA1c levels or The lowest HgbA1c possible without: Unacceptable variations in blood sugar Significant hypoglycemia

Slims Disease

Insulin Therapy

Insulins Types: (short acting -> long acting) R NPH L UL Humulin Humalog R NPH L UL NPH L UL Levemir Brands: Novolin Aventis Analog Novolog R Degludec Apidra Lantus

Rapid Short Intermediate Long Insulin Onset Peak Duration Humalog 15-20 min 30-90 min 3-4 hrs Novolog 15-20 min 40-50 min 3-4 hrs Regular 30-60 min 80-120 min 4-6 hrs NPH 2-4 hrs 6-10 hrs 14-16 hrs Lente 3-4 hrs 6-12 hrs 16-18 hrs Ultralene 4-6 hrs 10-16 hrs 18-20 hrs Lantus 2-3 hrs no peak 18-26 hrs Degludec

Insulin Dosage Insulin requirements Prepubertal 0.5-1.0 units/kg/day Pubertal 1.0-1.5 units/kg/day Components of Insulin dosing Usual daily dosing Correction of sporadic high blood glucose

Diabetes Mellitus Insulin Resistance/Allergy The vast majority of insulin resistance is due to: noncompliance

HbA1c and Blood Glucose Risk of diabetes related complications Low High Very High Your Goal 4%.60 5% 90 Best 6%..120 7%.150 8% 180 Better 9%..210 10%.240 11% 270 12%..300 13%.330 HbA1c Average blood glucose

Children with T1DM should have a HgbA1c checked: a. b. c. d. Monthly Every 3 months Every 6 months Annually

Children with T1DM should have a HgbA1c checked: a. b. c. d. Monthly Every 3 months Every 6 months Annually

Glycosylated Hemoglobin Measures average blood glucose over approximately the previous 2 3 months Should months be measured ~ every 3

HbA1 = 7.5 HbA1 = 7.5 Blood Glucose (mg/dl) 300 200 100 0 1 2 3 4 5 6 7 8 9 10 11 12

Office visits every 3-4 mos Blood lipids yearly Thyroid profile/autoantibodies yearly Urinary microalbumin yearly* Eye examination yearly* * 5 years after diagnosis or following onset of puberty

Dietary Management Composition of diet CHO 50-55% FAT 30% Protein 15-20%

Principles and Goals of Good Nutrition Eat less fat Eat more carbohydrates (starches and breads) especially those high in fiber Eat less simple sugars Use less salt Use alcohol only in moderation

Insulin Resistance and Disease in Children

Definition of Obesity Weight > 95th % Weight for Height > 95th % > 120 % Ideal Body Weight > 95th % BMI for Age & Sex BMI > 30

True or False An elevated BMI is a surrogate marker of insulin resistance?

BMI is a surrogate maker for Insulin Resistance

The Evolution of Type 2 Diabetes Mellitus Insulin resistance Blood glucose Insulin production Normal IFG / IGT T2DM Hyperinsulinemia T2DM Insulinopenia

Opportunities for Intervention Life Style Modification Prudent diet / Regular exercise / Smoking avoidance or cessation BMI Hyperinsulinism? Oral agents Oral agents IFG/IGT T2DM Insulin Oral agents Oral agents + Insulin Treat hypertension and hyperlipidemia when present T2DM Insulin Insulin

Insulin Resistance Obesity - Exercise